UPSTREAM BIO INC. - COMMON STOCK

Upstream Bio Reports Second Quarter 2025 Financial Results and Highlights Continued Progress

06 8 2025 04:00:00 提供 Nasdaq GlobeNewswire

Upstream Bio Announces First Patient Dosed in Phase 2 Clinical Trial of Verekitug in Chronic Obstructive Pulmonary Disease (COPD)

08 7 2025 04:00:00 提供 Nasdaq GlobeNewswire

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor

15 6 2025 04:45:00 提供 Nasdaq GlobeNewswire

Upstream Bio to Present Mechanistic Insights into Verekitug’s Enhanced Potency via TSLP Receptor Targeting at European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025

05 6 2025 04:00:00 提供 Nasdaq GlobeNewswire

Upstream Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

04 6 2025 04:00:00 提供 Nasdaq GlobeNewswire

Upstream Bio Appoints Stacy Price as Chief Technology Officer

20 5 2025 04:00:00 提供 Nasdaq GlobeNewswire

Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs

06 5 2025 04:00:00 提供 Nasdaq GlobeNewswire

Upstream Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

12 3 2025 04:00:00 提供 Nasdaq GlobeNewswire

Upstream Bio to Present at Upcoming March Investor Conferences

25 2 2025 05:00:01 提供 Nasdaq GlobeNewswire

Upstream Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference

06 1 2025 05:00:01 提供 Nasdaq GlobeNewswire

Upstream Bio Appoints Allison Ambrose as General Counsel

17 12 2024 05:00:00 提供 Nasdaq GlobeNewswire

Upstream Bio Announces Addition to Russell 2000® Index

16 12 2024 05:00:04 提供 Nasdaq GlobeNewswire

Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference

21 11 2024 05:00:00 提供 Nasdaq GlobeNewswire

Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights

07 11 2024 04:00:01 提供 Nasdaq GlobeNewswire

Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

15 10 2024 13:15:00 提供 Nasdaq GlobeNewswire